Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23


The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.

Antony J, Zanini E, Kelly Z, Tan TZ, Karali E, Alomary M, Jung Y, Nixon K, Cunnea P, Fotopoulou C, Paterson A, Roy-Nawathe S, Mills GB, Huang RY, Thiery JP, Gabra H, Recchi C.

EMBO Rep. 2018 Aug;19(8). pii: e45670. doi: 10.15252/embr.201745670. Epub 2018 Jun 15.


The Tumor-Suppressor Protein OPCML Potentiates Anti-EGFR- and Anti-HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer.

Zanini E, Louis LS, Antony J, Karali E, Okon IS, McKie AB, Vaughan S, El-Bahrawy M, Stebbing J, Recchi C, Gabra H.

Mol Cancer Ther. 2017 Oct;16(10):2246-2256. doi: 10.1158/1535-7163.MCT-17-0081. Epub 2017 Aug 3.


Visible-Light-Controlled Oxidation of Glucose using Titania-Supported Silver Photocatalysts.

Da Vià L, Recchi C, Davies TE, Greeves N, Lopez-Sanchez JA.

ChemCatChem. 2016 Nov 22;8(22):3475-3483. doi: 10.1002/cctc.201600775. Epub 2016 Oct 13.


The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer.

Antony J, Tan TZ, Kelly Z, Low J, Choolani M, Recchi C, Gabra H, Thiery JP, Huang RY.

Sci Signal. 2016 Oct 4;9(448):ra97.


Direct Targeting of the Ras GTPase Superfamily Through Structure- Based Design.

Zhao W, Jamshidiha M, Lanyon-Hogg T, Recchi C, Cota E, Tate EW.

Curr Top Med Chem. 2017;17(1):16-29. Review.


Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer.

Matassa DS, Amoroso MR, Lu H, Avolio R, Arzeni D, Procaccini C, Faicchia D, Maddalena F, Simeon V, Agliarulo I, Zanini E, Mazzoccoli C, Recchi C, Stronach E, Marone G, Gabra H, Matarese G, Landriscina M, Esposito F.

Cell Death Differ. 2016 Sep 1;23(9):1542-54. doi: 10.1038/cdd.2016.39. Epub 2016 May 20.


Correction: A Role for Na+,K+-ATPase α1 in Regulating Rab27a Localisation on Melanosomes.

Booth AE, Tarafder AK, Hume AN, Recchi C, Seabra MC.

PLoS One. 2016 Feb 3;11(2):e0148719. doi: 10.1371/journal.pone.0148719. eCollection 2016. No abstract available.


Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells.

Filipović A, Lombardo Y, Faronato M, Abrahams J, Aboagye E, Nguyen QD, d'Aqua BB, Ridley A, Green A, Rahka E, Ellis I, Recchi C, Przulj N, Sarajlić A, Alattia JR, Fraering P, Deonarain M, Coombes RC.

Breast Cancer Res Treat. 2014 Nov;148(2):455-62. doi: 10.1007/s10549-014-3119-z. Epub 2014 Sep 24. Erratum in: Breast Cancer Res Treat. 2014 Nov;148(2):463. Fronato, Monica [corrected to Faronato, Monica].


A role for Na+,K+-ATPase α1 in regulating Rab27a localisation on melanosomes.

Booth AE, Tarafder AK, Hume AN, Recchi C, Seabra MC.

PLoS One. 2014 Jul 22;9(7):e102851. doi: 10.1371/journal.pone.0102851. eCollection 2014. Erratum in: PLoS One. 2016;11(2):e0148719.


Respiratory infections cause the release of extracellular vesicles: implications in exacerbation of asthma/COPD.

Eltom S, Dale N, Raemdonck KR, Stevenson CS, Snelgrove RJ, Sacitharan PK, Recchi C, Wavre-Shapton S, McAuley DF, O'Kane C, Belvisi MG, Birrell MA.

PLoS One. 2014 Jun 27;9(6):e101087. doi: 10.1371/journal.pone.0101087. eCollection 2014.


Distinct and opposing roles for Rab27a/Mlph/MyoVa and Rab27b/Munc13-4 in mast cell secretion.

Singh RK, Mizuno K, Wasmeier C, Wavre-Shapton ST, Recchi C, Catz SD, Futter C, Tolmachova T, Hume AN, Seabra MC.

FEBS J. 2013 Feb;280(3):892-903. doi: 10.1111/febs.12081. Epub 2013 Jan 2.


Novel functions for Rab GTPases in multiple aspects of tumour progression.

Recchi C, Seabra MC.

Biochem Soc Trans. 2012 Dec 1;40(6):1398-403. doi: 10.1042/BST20120199. Review.


Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression.

Bobrie A, Krumeich S, Reyal F, Recchi C, Moita LF, Seabra MC, Ostrowski M, Théry C.

Cancer Res. 2012 Oct 1;72(19):4920-30. doi: 10.1158/0008-5472.CAN-12-0925. Epub 2012 Aug 3.


Rab27a-mediated protease release regulates neutrophil recruitment by allowing uropod detachment.

Singh RK, Liao W, Tracey-White D, Recchi C, Tolmachova T, Rankin SM, Hume AN, Seabra MC.

J Cell Sci. 2012 Apr 1;125(Pt 7):1652-6. doi: 10.1242/jcs.100438. Epub 2012 Feb 28.


MT1-MMP-dependent invasion is regulated by TI-VAMP/VAMP7.

Steffen A, Le Dez G, Poincloux R, Recchi C, Nassoy P, Rottner K, Galli T, Chavrier P.

Curr Biol. 2008 Jun 24;18(12):926-31. doi: 10.1016/j.cub.2008.05.044.


The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA.

Sakurai-Yageta M, Recchi C, Le Dez G, Sibarita JB, Daviet L, Camonis J, D'Souza-Schorey C, Chavrier P.

J Cell Biol. 2008 Jun 16;181(6):985-98. doi: 10.1083/jcb.200709076. Epub 2008 Jun 9.


V-ATPase: a potential pH sensor.

Recchi C, Chavrier P.

Nat Cell Biol. 2006 Feb;8(2):107-9. No abstract available.


Mycobacterium tuberculosis Rv1395 is a class III transcriptional regulator of the AraC family involved in cytochrome P450 regulation.

Recchi C, Sclavi B, Rauzier J, Gicquel B, Reyrat JM.

J Biol Chem. 2003 Sep 5;278(36):33763-73. Epub 2003 Jun 25.


The allele encoding the mycobacterial Erp protein affects lung disease in mice.

de Mendonça-Lima L, Bordat Y, Pivert E, Recchi C, Neyrolles O, Maitournam A, Gicquel B, Reyrat JM.

Cell Microbiol. 2003 Jan;5(1):65-73.


Signal-sequence-independent secretion of the staphylococcal nuclease in Mycobacterium smegmatis.

Recchi C, Rauzier J, Gicquel B, Reyrat JM.

Microbiology. 2002 Feb;148(Pt 2):529-36.


Anthrax lethal factor cleaves the N-terminus of MAPKKS and induces tyrosine/threonine phosphorylation of MAPKS in cultured macrophages

Vitale G, Pellizzari R, Recchi C, Napolitani G, Mock M, Montecucco C.

J Appl Microbiol. 1999 Aug;87(2):288.


Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.

Vitale G, Pellizzari R, Recchi C, Napolitani G, Mock M, Montecucco C.

Biochem Biophys Res Commun. 1998 Jul 30;248(3):706-11.


Evaluation of five new liquid stable applications on the Roche Cobas Integra.

Lippi G, Brentegani C, Mazzi C, Recchi C, Ruzzenente O, Guidi G.

Eur J Clin Chem Clin Biochem. 1997 Nov;35(11):877-80.


Supplemental Content

Loading ...
Support Center